State Board of Administration of Florida Retirement System raised its position in shares of Schrödinger, Inc. (NASDAQ:SDGR – Get Rating) by 25.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 21,782 shares of the company’s stock after purchasing an additional 4,470 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Schrödinger were worth $575,000 as of its most recent SEC filing.
Several other hedge funds have also recently modified their holdings of SDGR. Wellington Shields Capital Management LLC bought a new position in Schrödinger during the first quarter valued at $44,000. US Bancorp DE increased its holdings in Schrödinger by 69.2% in the 1st quarter. US Bancorp DE now owns 1,932 shares of the company’s stock worth $66,000 after buying an additional 790 shares during the period. Capital Advisors Ltd. LLC acquired a new stake in shares of Schrödinger during the 1st quarter worth approximately $68,000. SG Americas Securities LLC raised its holdings in shares of Schrödinger by 19.7% during the 2nd quarter. SG Americas Securities LLC now owns 3,993 shares of the company’s stock worth $105,000 after acquiring an additional 657 shares during the period. Finally, Banque Cantonale Vaudoise increased its position in shares of Schrödinger by 40.7% during the 2nd quarter. Banque Cantonale Vaudoise now owns 4,150 shares of the company’s stock worth $109,000 after purchasing an additional 1,200 shares during the last quarter. Hedge funds and other institutional investors own 65.45% of the company’s stock.
Schrödinger Price Performance
Schrödinger stock opened at $18.66 on Friday. The stock’s 50-day moving average is $23.82 and its 200-day moving average is $26.56. The company has a market cap of $1.33 billion, a price-to-earnings ratio of -8.72 and a beta of 1.07. Schrödinger, Inc. has a 12 month low of $18.62 and a 12 month high of $42.09.
Wall Street Analyst Weigh In
Schrödinger, Inc, together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries.
- Get a free copy of the StockNews.com research report on Schrödinger (SDGR)
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
- How High Can the Fed Go? How to Trade it
- Verra Mobility Stock Has Returned Back to the Station
- Does ASML’s November Rally Have Staying Power?
Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.